8,958 trials (keyword fallback)
Non ST Elevation Myocardial Infarction
Primary: Major Adverse Cardiac and Cerebrovascular Events (MACCE) — 35.3; 13.8 Percentage of study group
Telehealth · Coronary Artery Bypass Surgery
Primary: Cardiac Symptom Distress Score — 15.24; 12.84; 12.81; 11.87 scores on a scale
Coronary Arterial Disease (CAD)
Primary: 888 Number of Participants With Major Adverse Cardiac Events (MACE) at 30 Days — 0 participants
Myocardial Ischemia
Primary: Quantification of Myocardial Blood Volume — 3.63; 1.23 seconds^-1
Coronary Artery Disease · Atherosclerosis · Inflammation
Primary: C-Reactive Protein (CRP) — 3.7; 4.6 mg/L
Kawasaki Disease
Primary: Number of Participants With Treatment-related Adverse Events — 0 Participants
Kawasaki Disease
Primary: Number of Participants With SAE — 4 Participants
Kawasaki Disease
Primary: Number of Participants With Adverse Events — 2; 3; 13 participants
Coronary Heart Disease
Primary: Myocardial Perfusion — 1.83; 1.52 myocardial perfusion index
Coronary Disease · Coronary Stenosis
Primary: MACCE — 80; 51 Participants — p=0.35
Coronary Artery Disease
Primary: Major Adverse Coronary and Cerebrovascular Events (MACCE) — 0.130; 0.111 MACCE Event Rate per Person-Year
Stable Ischemic Heart Disease
Primary: Exercise Treadmill Scores — 0.771; 0.772; 0.768 Probability by AUC
Diabetes, Type I · Diabetes, Type II · Angina
Primary: Change in Post-exercise Coronary Vasodilator Reserve — -4; 2 % change
Coronary Artery Diseases · Multivessel Coronary Artery Disease · Heart Diseases
Primary: Inter-rater Agreement on Revascularization Strategy of Two Heart Teams Using an "Angio-first" Algorithm or a "CT First" Algorithm. — 0.82 proportion of agreement
Coronary Artery Disease
Primary: Total Percutaneous Coronary Intervention (PCI) Iodinated Contrast Volume — 64.6; 90.8 ml